Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.
Also called NCT01670318
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 800 participants
- Sponsor
- The PCI Guideline Research Society
- Registry
-
NCT01670318
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Unknown status
Technical summary
Registry record NCT01670318. Non-randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets
- Acronym
- SPECIALIST
- Condition
- Coronary Artery Disease
- Intervention (Device)
- platinum chromium everolimus-eluting stent (PROMUS Element by Boston Scientific, Massachusetts)
- Lead sponsor
- The PCI Guideline Research Society
Record details
- Record id
cardio:ct-nct01670318- Content hash
d458d3822cf26bcf07a6f2ff613ad48acc138ad79275aa30a9a5f55a6aaf0037